Moderna expects vaccine to be effective against coronavirus variants

U.S. biotechnology firm Moderna Inc. said Wednesday that its COVID-19 vaccine is expected to be protective against variants of the novel coronavirus recently detected in Britain, based on data to date."We will be performing additional tests of the vaccine in the coming weeks to confirm this expectation," the Massachusetts-based company added in its statement.It also said it has tested sera from animals and humans vaccinated with its COVID-19 vaccine against a number of previous variants of the virus that have emerged since the first outbreak of the pandemic, and found it to "remain equally …READ FULL ARTICLE